Welcome to Less Pain Better Performance Mini-Course

 

'Know Pain Know Gain'

 

Unveiling the future of performance training

 
Can't wait for the next video?
Did you know that elevated performance from an individual has been proven to raise their teammates’ performance too?

 

These are the findings of Professor of Medicine at the University of Adelaide, Mark Hutchinson, who has also developed blood tests that predict performance, allowing adjustments to be made to ensure athletes gain maximum benefit from each session.

As Director of the ARC Centre of Excellence for Nanoscale BioPhotonics, Mark is at the cutting-edge of understanding the relationship between pain and performance and will be sharing his expertise at the forthcoming Less Pain Better Performance event in November.

Mark said: “Dealing with pain and human cognition is ultimately the connectivity between the mind and body. We are right at the beginning of a new generation of athletes who will be able to train at a higher level, closer to the edge, because they can see what their biomarkers show and respond accordingly.”

Less Pain Better Performance is a four-day online program aimed at anyone training others to achieve their personal best.

Mark will explore latest developments in pain, human performance and precision technologies, enabling participants to…

  • Understand the technology that is revealing the fundamental neurobiology at play in performance and pain.
  • Consider the role that biomarker technology could have on their own elite training.
  • Glimpse the exciting future of applying biology and technology to achieve augmented human performance.

 

About Mark

Professor Hutchinson is the Director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), an Australian Research Council Future Fellow and a Professor within the Adelaide Medical School at the University of Adelaide. Mark is also President of Science and Technology Australia, the peak body in Australia that represents 90,000 scientists. Mark serves as a founding member of the Operating in Contaminated Environments Advisory Council for the DSTG CBRN STaRShot and as a Ministerial appointment to the ARC CEO Advisory Council. He is an early adopter of new technologies and computational approaches.

 
For example this lab summary is generated with AI natural text. The Neuroimmunopharmacology Laboratory is a world-leading research team, whose main focus is to develop innovative technologies that allow for the early diagnosis and treatment of neurological diseases. Our innovation centre focuses on translational science, developing biomarkers and wearables for real-time monitoring and precision medicine.

 

To attend Mark’s session and gain access to over 16 hours of outcome-focused learning, click below to sign up for Less Pain Better Performance.